VBIV Annual Net Income
-$92.84 M
+$20.47 M+18.06%
31 December 2023
Summary:
As of January 21, 2025, VBIV annual net profit is -$92.84 million, with the most recent change of +$20.47 million (+18.06%) on December 31, 2023. During the last 3 years, it has fallen by -$46.61 million (-100.81%).VBIV Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBIV Quarterly Net Income
-$17.90 M
-$17.89 M-137592.31%
31 March 2024
Summary:
As of January 21, 2025, VBIV quarterly net profit is -$17.90 million, with the most recent change of -$17.89 million (-137592.31%) on March 31, 2024. Over the past year, it has increased by +$26.73 million (+59.89%).VBIV Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBIV TTM Net Income
-$82.98 M
+$9.85 M+10.61%
31 March 2024
Summary:
As of January 21, 2025, VBIV TTM net profit is -$82.98 million, with the most recent change of +$9.85 million (+10.61%) on March 31, 2024. Over the past year, it has increased by +$35.74 million (+30.11%).VBIV TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBIV Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +18.1% | +59.9% | +30.1% |
| 3 y3 years | -100.8% | +15.3% | +26.8% |
| 5 y5 years | -46.0% | +15.3% | +26.8% |
VBIV Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | >+9999.0% | <-9999.0% | >+9999.0% |
VBI Vaccines Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | -$17.90 M(>+9900.0%) | -$82.98 M(-10.6%) |
| Dec 2023 | -$92.84 M(-18.1%) | -$13.00 K(-99.9%) | -$92.84 M(-18.5%) |
| Sept 2023 | - | -$20.44 M(-54.2%) | -$113.96 M(-4.0%) |
| June 2023 | - | -$44.63 M(+60.8%) | -$118.73 M(-0.9%) |
| Mar 2023 | - | -$27.75 M(+31.3%) | -$119.80 M(+5.7%) |
| Dec 2022 | -$113.30 M(+62.4%) | -$21.14 M(-16.1%) | -$113.30 M(+2.1%) |
| Sept 2022 | - | -$25.21 M(-44.8%) | -$110.94 M(+9.2%) |
| June 2022 | - | -$45.70 M(+115.0%) | -$101.58 M(+38.5%) |
| Mar 2022 | - | -$21.25 M(+13.2%) | -$73.36 M(+5.2%) |
| Dec 2021 | -$69.75 M(+50.9%) | -$18.78 M(+18.5%) | -$69.75 M(+5.2%) |
| Sept 2021 | - | -$15.85 M(-9.3%) | -$66.33 M(+4.5%) |
| June 2021 | - | -$17.48 M(-1.0%) | -$63.48 M(+14.3%) |
| Mar 2021 | - | -$17.65 M(+14.9%) | -$55.52 M(+20.1%) |
| Dec 2020 | -$46.23 M(-15.7%) | -$15.36 M(+18.2%) | -$46.23 M(+10.7%) |
| Sept 2020 | - | -$13.00 M(+36.6%) | -$41.74 M(-7.0%) |
| June 2020 | - | -$9.51 M(+13.8%) | -$44.91 M(-7.5%) |
| Mar 2020 | - | -$8.36 M(-23.1%) | -$48.56 M(-11.4%) |
| Dec 2019 | -$54.81 M(-13.8%) | -$10.88 M(-32.7%) | -$54.81 M(-13.3%) |
| Sept 2019 | - | -$16.16 M(+22.7%) | -$63.19 M(+1.3%) |
| June 2019 | - | -$13.17 M(-9.8%) | -$62.40 M(-5.4%) |
| Mar 2019 | - | -$14.61 M(-24.1%) | -$65.96 M(+3.7%) |
| Dec 2018 | -$63.60 M(+63.1%) | -$19.25 M(+25.2%) | -$63.60 M(+13.8%) |
| Sept 2018 | - | -$15.37 M(-8.1%) | -$55.90 M(+11.1%) |
| June 2018 | - | -$16.73 M(+36.6%) | -$50.33 M(+18.1%) |
| Mar 2018 | - | -$12.25 M(+6.1%) | -$42.61 M(+9.3%) |
| Dec 2017 | -$38.99 M(+68.0%) | -$11.54 M(+17.8%) | -$39.00 M(+8.7%) |
| Sept 2017 | - | -$9.80 M(+8.8%) | -$35.86 M(+7.5%) |
| June 2017 | - | -$9.01 M(+4.3%) | -$33.36 M(+8.4%) |
| Mar 2017 | - | -$8.64 M(+2.7%) | -$30.76 M(+32.6%) |
| Dec 2016 | -$23.20 M(-11.4%) | -$8.41 M(+15.2%) | -$23.20 M(-25.4%) |
| Sept 2016 | - | -$7.30 M(+13.8%) | -$31.11 M(+1.3%) |
| June 2016 | - | -$6.42 M(+494.6%) | -$30.70 M(+17.9%) |
| Mar 2016 | - | -$1.08 M(-93.4%) | -$26.03 M(-70.3%) |
| Dec 2015 | -$26.19 M(-60.3%) | -$16.32 M(+137.0%) | -$87.78 M(+20.7%) |
| Sept 2015 | - | -$6.88 M(+293.9%) | -$72.75 M(+9.1%) |
| June 2015 | - | -$1.75 M(-97.2%) | -$66.68 M(+1.0%) |
| Mar 2015 | - | -$62.83 M(+4782.7%) | -$66.05 M(+1302.7%) |
| Mar 2015 | -$65.92 M(+1334.9%) | - | - |
| Dec 2014 | - | -$1.29 M(+57.8%) | -$4.71 M(-6.1%) |
| Sept 2014 | - | -$815.40 K(-26.7%) | -$5.01 M(-5.2%) |
| June 2014 | - | -$1.11 M(-25.5%) | -$5.28 M(+14.1%) |
| Mar 2014 | -$4.59 M(-30.9%) | -$1.49 M(-6.1%) | -$4.63 M(+34.0%) |
| Dec 2013 | - | -$1.59 M(+46.2%) | -$3.46 M(+17.8%) |
| Sept 2013 | - | -$1.09 M(+135.8%) | -$2.93 M(-44.4%) |
| June 2013 | - | -$461.40 K(+45.6%) | -$5.28 M(-20.6%) |
| Mar 2013 | -$6.65 M(-49.4%) | -$317.00 K(-70.3%) | -$6.65 M(-30.6%) |
| Dec 2012 | - | -$1.07 M(-68.9%) | -$9.58 M(-15.2%) |
| Sept 2012 | - | -$3.43 M(+87.4%) | -$11.30 M(+1.5%) |
| June 2012 | - | -$1.83 M(-43.6%) | -$11.13 M(-16.3%) |
| Mar 2012 | -$13.15 M | -$3.25 M(+16.4%) | -$13.31 M(-53.2%) |
| Dec 2011 | - | -$2.79 M(-14.6%) | -$28.45 M(+3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2011 | - | -$3.27 M(-18.5%) | -$27.56 M(-1.1%) |
| June 2011 | - | -$4.01 M(-78.2%) | -$27.86 M(+10.7%) |
| Mar 2011 | -$25.35 M(+3436.2%) | -$18.39 M(+868.7%) | -$25.17 M(+251.5%) |
| Dec 2010 | - | -$1.90 M(-46.6%) | -$7.16 M(+31.9%) |
| Sept 2010 | - | -$3.56 M(+169.6%) | -$5.43 M(+178.8%) |
| June 2010 | - | -$1.32 M(+243.7%) | -$1.95 M(+175.5%) |
| Mar 2010 | -$717.00 K(+173.7%) | -$383.90 K(+130.8%) | -$706.60 K(+77.6%) |
| Dec 2009 | - | -$166.30 K(+116.0%) | -$397.90 K(+35.8%) |
| Sept 2009 | - | -$77.00 K(-3.0%) | -$292.90 K(-3.5%) |
| June 2009 | - | -$79.40 K(+5.6%) | -$303.50 K(+7.2%) |
| Mar 2009 | -$262.00 K(-53.1%) | -$75.20 K(+22.7%) | -$283.10 K(-15.2%) |
| Dec 2008 | - | -$61.30 K(-30.0%) | -$334.00 K(-23.0%) |
| Sept 2008 | - | -$87.60 K(+48.5%) | -$433.90 K(-18.9%) |
| June 2008 | - | -$59.00 K(-53.2%) | -$535.10 K(-3.1%) |
| Mar 2008 | -$558.40 K(+172.0%) | -$126.10 K(-21.8%) | -$552.20 K(+30.0%) |
| Dec 2007 | - | -$161.20 K(-14.6%) | -$424.70 K(+31.5%) |
| Sept 2007 | - | -$188.80 K(+148.1%) | -$323.00 K(+44.9%) |
| June 2007 | - | -$76.10 K(-5535.7%) | -$222.90 K(+4.7%) |
| Mar 2007 | -$205.30 K(-44.3%) | $1400.00(-102.4%) | -$212.80 K(-53.5%) |
| Dec 2006 | - | -$59.50 K(-32.9%) | -$457.90 K(+5.7%) |
| Sept 2006 | - | -$88.70 K(+34.4%) | -$433.20 K(+10.4%) |
| June 2006 | - | -$66.00 K(-72.9%) | -$392.40 K(+6.4%) |
| Mar 2006 | -$368.80 K(+617.5%) | -$243.70 K(+600.3%) | -$368.70 K(+262.5%) |
| Dec 2005 | - | -$34.80 K(-27.3%) | -$101.70 K(+20.6%) |
| Sept 2005 | - | -$47.90 K(+13.2%) | -$84.30 K(+46.4%) |
| June 2005 | - | -$42.30 K(-281.5%) | -$57.60 K(+57.8%) |
| Mar 2005 | -$51.40 K(-62.5%) | $23.30 K(-233.9%) | -$36.50 K(-58.9%) |
| Dec 2004 | - | -$17.40 K(-17.9%) | -$88.80 K(-24.4%) |
| Sept 2004 | - | -$21.20 K(0.0%) | -$117.40 K(-7.0%) |
| June 2004 | - | -$21.20 K(-26.9%) | -$126.20 K(-6.1%) |
| Mar 2004 | -$137.10 K(+52.5%) | -$29.00 K(-37.0%) | -$134.40 K(-12.1%) |
| Dec 2003 | - | -$46.00 K(+53.3%) | -$152.90 K(+32.2%) |
| Sept 2003 | - | -$30.00 K(+2.0%) | -$115.70 K(+10.5%) |
| June 2003 | - | -$29.40 K(-38.1%) | -$104.70 K(+21.7%) |
| Mar 2003 | -$89.90 K(-84.0%) | -$47.50 K(+439.8%) | -$86.00 K(-84.7%) |
| Dec 2002 | - | -$8800.00(-53.7%) | -$561.90 K(-0.5%) |
| Sept 2002 | - | -$19.00 K(+77.6%) | -$564.60 K(+1.5%) |
| June 2002 | - | -$10.70 K(-98.0%) | -$556.20 K(-1.5%) |
| Mar 2002 | -$563.40 K(+200.2%) | -$523.40 K(+4451.3%) | -$564.40 K(+358.1%) |
| Dec 2001 | - | -$11.50 K(+8.5%) | -$123.20 K(-7.6%) |
| Sept 2001 | - | -$10.60 K(-43.9%) | -$133.40 K(-27.7%) |
| June 2001 | - | -$18.90 K(-77.0%) | -$184.60 K(+11.4%) |
| Mar 2001 | -$187.70 K(+172.8%) | -$82.20 K(+278.8%) | -$165.70 K(+98.9%) |
| Dec 2000 | - | -$21.70 K(-64.9%) | -$83.30 K(+35.2%) |
| Sept 2000 | - | -$61.80 K(<-9900.0%) | -$61.60 K(-9.3%) |
| Mar 2000 | -$68.80 K(-65.4%) | $200.00(-100.3%) | -$67.90 K(-66.4%) |
| Sept 1999 | - | -$68.10 K(-49.1%) | -$201.90 K(+1.3%) |
| Mar 1999 | -$198.80 K(-43.6%) | -$133.80 K(+104.3%) | -$199.30 K(-42.7%) |
| Sept 1998 | - | -$65.50 K(-76.8%) | -$347.90 K(+23.2%) |
| Mar 1998 | -$352.20 K(+62.0%) | -$282.40 K | -$282.40 K |
| Mar 1997 | -$217.40 K | - | - |
FAQ
- What is VBI Vaccines annual net profit?
- What is the all time high annual net income for VBI Vaccines?
- What is VBI Vaccines annual net income year-on-year change?
- What is VBI Vaccines quarterly net profit?
- What is the all time high quarterly net income for VBI Vaccines?
- What is VBI Vaccines quarterly net income year-on-year change?
- What is VBI Vaccines TTM net profit?
- What is the all time high TTM net income for VBI Vaccines?
- What is VBI Vaccines TTM net income year-on-year change?
What is VBI Vaccines annual net profit?
The current annual net income of VBIV is -$92.84 M
What is the all time high annual net income for VBI Vaccines?
VBI Vaccines all-time high annual net profit is -$51.40 K
What is VBI Vaccines annual net income year-on-year change?
Over the past year, VBIV annual net profit has changed by +$20.47 M (+18.06%)
What is VBI Vaccines quarterly net profit?
The current quarterly net income of VBIV is -$17.90 M
What is the all time high quarterly net income for VBI Vaccines?
VBI Vaccines all-time high quarterly net profit is $23.30 K
What is VBI Vaccines quarterly net income year-on-year change?
Over the past year, VBIV quarterly net profit has changed by +$26.73 M (+59.89%)
What is VBI Vaccines TTM net profit?
The current TTM net income of VBIV is -$82.98 M
What is the all time high TTM net income for VBI Vaccines?
VBI Vaccines all-time high TTM net profit is -$36.50 K
What is VBI Vaccines TTM net income year-on-year change?
Over the past year, VBIV TTM net profit has changed by +$35.74 M (+30.11%)